7575 logo

Japan Lifeline Co., Ltd. Stock Price

TSE:7575 Community·JP¥102.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

7575 Share Price Performance

JP¥1,464.00
204.00 (16.19%)
JP¥1,464.00
204.00 (16.19%)
Price JP¥1,464.00

7575 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

0 Risks
5 Rewards

Japan Lifeline Co., Ltd. Key Details

JP¥57.9b

Revenue

JP¥23.1b

Cost of Revenue

JP¥34.8b

Gross Profit

JP¥25.1b

Other Expenses

JP¥9.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
137.72
60.07%
16.67%
5.8%
View Full Analysis

About 7575

Founded
1981
Employees
1250
CEO
Keisuke Suzuki
WebsiteView website
www.japanlifeline.com

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and aspiration catheter neurovascular intervention product. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Recent 7575 News & Updates

Japan Lifeline's (TSE:7575) Upcoming Dividend Will Be Larger Than Last Year's

Oct 31
Japan Lifeline's (TSE:7575) Upcoming Dividend Will Be Larger Than Last Year's

Recent updates

No updates